hematopoietic system
immune system
Allele Symbol Allele Name Allele ID |
Tcratm1Mass targeted mutation 1, Marc Schmidt-Supprian MGI:5532653 |
||||||||||||||||||||
Summary |
4 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• uninduced mice exhibit an increase in tetramer+ T cells due to leaky cre expression
|
• TCR-switched T cells treated with pIpC induce sterile inflammation in recipient mice possibly due to autoimmune activation
• however, recipient mice treated with galactosylceramide do not exhibit induction of NK T cell differentiation of TCR-switched tetramer+ T cells
|
• uninduced mice exhibit an increase in tetramer+ T cells due to leaky cre expression
|
• TCR-switched T cells treated with pIpC induce sterile inflammation in recipient mice possibly due to autoimmune activation
• however, recipient mice treated with galactosylceramide do not exhibit induction of NK T cell differentiation of TCR-switched tetramer+ T cells
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• perturbed
|
• in the thymus and spleen
|
• perturbed
|
• in the thymus and spleen
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• abnormal NK T cell maturation
|
• 23 times more in the thymus
• 43 times more in the spleen
• in mice treated with galactosylceramide
|
• abnormal NK T cell maturation
|
• 23 times more in the thymus
• 43 times more in the spleen
• in mice treated with galactosylceramide
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|